Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Analysis of Radiation Therapy Quality Assurance in NRG Oncology RTOG 0848.
Journal: International journal of radiation oncology, biology, physics
Published: March 08, 2023
Drug-Eluting Bead, Irinotecan Therapy of Unresectable Intrahepatic Cholangiocarcinoma (DELTIC) with Concomitant Systemic Gemcitabine and Cisplatin.
Journal: Annals of surgical oncology
Published: February 07, 2022
Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-Mesothelin (CRS-207) with or without Nivolumab in Patients with Pancreatic Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 22, 2019
Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: KEYNOTE-164.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 15, 2019
TGFβ suppresses CD8+ T cell expression of CXCR3 and tumor trafficking.
Journal: Nature communications
Published: September 12, 2019
Expert Consensus Document on Pulmonary Metastasectomy.
Journal: The Annals of thoracic surgery
Published: September 30, 2018
Results from a Phase IIb, Randomized, Multicenter Study of GVAX Pancreas and CRS-207 Compared with Chemotherapy in Adults with Previously Treated Metastatic Pancreatic Adenocarcinoma (ECLIPSE Study).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 19, 2018
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.
Journal: Science (New York, N.Y.)
Published: May 17, 2017
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial.
Journal: Lancet (London, England)
Published: November 23, 2016
A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinoma.
Journal: Journal for immunotherapy of cancer
Published: February 17, 2016
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.
Journal: The New England journal of medicine
Published: June 02, 2015
Comparison of local reactions to oxaliplatin infusions by peripheral versus central venous administration.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: March 13, 2015
Last Updated: 09/26/2026